Question 1

What is the catalog number for GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA?

Accepted Answer

The catalog number for GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA is KBVH015-38_.

Question 2

Is GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA in stock?

Accepted Answer

GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

CD16 (C16/1045), CF405S conjugate, 0.1mg/mL

Cytokeratin 17 (E3), CF488A conjugate, 0.1mg/mL

CD74 (BU45), Biotin conjugate, 0.1mg/mL

Cytokeratin 8 (KRT8) (B22.1), CF740 conjugate, 0.1mg/mL

SOX10 (SOX10/1074), CF488A conjugate, 0.1mg/mL

TAG-72 / CA72.4 (B72.3 + CA72/733), CF740 conjugate, 0.1mg/mL